Fang Jing J - OmicsDI

Show results for

Unknown (202)
Proteomics (39)
Metabolomics (4)
Genomics (3)
Transcriptomics (2)
Models (1)

Organisms

Homo sapiens (21)
Escherichia coli (5)
Mus musculus (4)
Aerococcus urinae NBRC 15544 = CCUG 36881 (4)
Andropogon gerardi (4)
Bacteria (4)
Bartonella quintana JK 31 (4)
Canis lupus familiaris (4)
Cnidaria (4)
Ectopseudomonas oleovorans CECT 5344 (4)
Ensifer adhaerens (4)
Halictus scabiosae (4)
Human immunodeficiency virus 1 (4)
Mesocricetus auratus (4)
Miscanthus x giganteus (4)
Morchella importuna (4)
Mus musculus (4)
Panicum virgatum (4)
Pseudomonas aeruginosa PA103 (4)
Pseudomonas aeruginosa SJTD-1 (4)
Rabies virus Nishigahara RCEH (4)
Rattus norvegicus (4)
Mycobacterium tuberculosis H37Rv_2009 (2)
Bos taurus (1)
Chlorocebus sabaeus (1)
Drosophila melanogaster (1)
Ophiocordyceps sinensis (1)
Oryza sativa (1)
Plasmodium yoelii yoelii 17XNL (1)
Severe acute respiratory syndrome coronavirus 2 (1)

Repository

iProX (33)
MetaboLights (4)
pride (4)
EGA (3)
biostudies-arrayexpress (2)
MassIVE (2)
BioModels (1)

Tissue

Cell culture (2)
Mammary gland epithelial cell (1)
Peripheral blood mononuclear cell (1)

Disease

Breast cancer (1)
Melanoma (1)

Technology Type

Mass Spectrometry (4)
Shotgun proteomics (4)
Mass spectrometry (2)
Mass spectrometry assay (2)
Illumina HiSeq 2000 (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (3)
Liquid Chromatography MS - positive - reverse phase (3)
Orbitrap Elite mass spectrometer(Thermo) (1)
Orbitrap Fusion (1)
Liquid Chromatography MS - (1)

Publication Date

2021 (9)
2024 (8)
2022 (8)
2023 (6)
2025 (4)
2015 (3)
2026 (3)
2020 (2)
2019 (1)
2017 (1)
2016 (1)

CHEBI ID

CHEBI:51686 (2)
CHEBI:136156 (2)
CHEBI:183673 (2)
CHEBI:53678 (2)
CHEBI:37025 (2)
CHEBI:183846 (2)
CHEBI:9107 (2)
CHEBI:183723 (2)
CHEBI:16796 (2)
CHEBI:28324 (2)
CHEBI:27407 (2)
CHEBI:2877 (2)
CHEBI:21363 (2)
CHEBI:73018 (2)
CHEBI:68503 (2)
CHEBI:72736 (2)
CHEBI:27974 (2)
CHEBI:17521 (2)
CHEBI:168507 (2)
CHEBI:69081 (2)
CHEBI:168762 (2)
CHEBI:3291 (2)
CHEBI:17026 (2)
CHEBI:28941 (2)
CHEBI:28997 (2)
CHEBI:23965 (2)
CHEBI:89836 (2)
CHEBI:40410 (2)
CHEBI:64032 (2)
CHEBI:17033 (2)

Metabolite Name

D-2-Aminoadipic acid (2)
O-Acetyl-L-carnitine (2)
Citrulline (2)
4-Pyridoxic acid (2)
N-Acetylglycine (2)
Ornithine (2)
LPE 18:2 (2)
N-Acetylneuraminic acid (2)
Taurine (2)
Ascorbic acid (2)
LPC 18:1 (2)
LPC 18:2 (2)
Citraconic acid (2)
Cholic acid (2)
Theophylline (2)
Stearic acid (2)
Arachidonic acid (2)
L-Glutamic acid (2)
Royal jelly acid (2)
Pseudouridine (2)
YOHIMBIC ACID HYDRATE (1)
Vicriviroc Malate (1)
Thymol-beta-D-glucoside (1)
Solorinin (1)
Smenospongiarine (1)
Reynosin (1)
Phosphatidylserine 19 (1)
Phosphatidylethanolamine 19 (1)
Phosphatidylethanolamine 18 (1)
Phosphatidylethanolamine 17 (1)

IsPrivate

False (1)

Model Flag

Non Kinetic (1)

Modelling Approach

Constraint-based model (1)

Study type

Transcription profiling by array (1)
RNA-seq of coding RNA (1)

Release Date

2023 (34)
2025 (33)
2022 (29)
2024 (21)
2021 (21)
2020 (19)
2015 (10)
2019 (6)
2018 (6)
2016 (6)
2026 (5)
2014 (5)
2017 (3)
2011 (3)
2013 (2)
2010 (1)

Lab affiliation

Dalian medical university (1)
Department of Genetics, Medical College of Soochow University, Suzhou 215123, China. (1)
Department of breast surgical oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China (1)
Hubei University of Technology (1)

Previous page
1 / 26
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 26
Next page

Sort by:

Relevance

Page size

Metabolomic analysis of anti-hypoxia and anti-anxiety effects of Fu Fang Jin Jing Oral Liquid.

Not available

S-EPMC3799728 | biostudies-literature

Potential mechanism of action of Jing Fang Bai Du San in the treatment of COVID-19 using docking and network pharmacology.

Not available

S-EPMC8795796 | biostudies-literature

Vitamin D receptor protein expression in tumor tissue and prostate cancer progression.

Not available

S-EPMC3107752 | biostudies-literature

Investigating continuation of folic acid supplementation during peri-conceptional period: a community-based cross-sectional study.

Not available

S-EPMC9942345 | biostudies-literature

Myeloid-specific blockade of Notch signaling ameliorates nonalcoholic fatty liver disease in mice.

Not available

S-EPMC10092768 | biostudies-literature

Fang2011 - Genome-scale metabolic network of Burkholderia cenocepacia (iKF1028)

Fang2011 - Genome-scale metabolic network of Burkholderia cenocepacia (iKF1028) This model is described in the article: Exploring the metabolic network of the epidemic pathogen Burkholderia cenocepacia J2315 via genome-scale reconstruction. Fang K, Zhao H, Sun C, Lam CM, Chang...

2015-07-30 | MODEL1507180051 | BioModels

Cellular senescence primes liver fibrosis regression through Notch-EZH2.

Not available

S-EPMC10442476 | biostudies-literature

CD24 genetic variants contribute to overall survival in patients with gastric cancer.

Not available

S-EPMC4735012 | biostudies-literature

A peptide CORO1C-47aa encoded by circ-0000437 functions as a negative regulator in endometrium tumor angiogenesis

Circular RNAs (circRNA) are a novel class of widespread non-coding RNAs (ncRNAs) that regulate gene expression in mammals. Recent studies demonstrate that functional peptides can be encoded by short open reading frames (sORFs) in ncRNAs, including circRNAs. In this study, through deep RNA sequencing...

ORGANISM(S): Homo sapiens (Human)

2022-02-17 | PXD026046 | Pride

Short-term tamoxifen administration improves hepatic steatosis and glucose intolerance through JNK/MAPK in mice.

Not available

S-EPMC9981902 | biostudies-literature

Previous page
1 / 26
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 26
Next page

Sort by:

Relevance

Page size

251 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

IsPrivate

Model Flag

Modelling Approach

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets